Jim Cramer on Pfizer: "The Drug Stocks Are Just in a World of Hurt, and This One Continues to Be There"

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently talked about. During the lightning round, when a caller asked about the stock, Cramer commented:

“I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to change it. But right now, the drug stocks are just in a world of hurt, and this one continues to be there. You can own it. They gotta figure out something. That yield will protect you for a while, though.”

Pfizer Inc. (NYSE:PFE) researches, develops, and manufactures biopharmaceutical products and vaccines. Cramer discussed it during the September 22 episode of Squawk on the Street. He said:

“Pfizer is being viewed as a company that doesn’t really have anything. Meaning that people feel that the Seagen acquisition didn’t pay off. That was a very big acquisition. I don’t wanna write them off, but it’s kind of like cholesterol. . .where you finally just, you know you got a number of players in it, and everybody did well. I think that can happen here.”

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.